Overview

Efficacy of Antioxidant Therapy Compared With Enalapril in Sickle Nephropathy

Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether enalapril or antioxidant therapy (N-Acetylcysteine) is effective in reducing microalbuminuria in children with sickle cell disease and and its progression to sickle nephropathy
Phase:
N/A
Details
Lead Sponsor:
The University of The West Indies
Collaborator:
Caribbean Health Research Council
Treatments:
Acetylcysteine
Antioxidants
Enalapril
Enalaprilat
N-monoacetylcystine